{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:25:05Z","timestamp":1791401105649,"version":"4.3.3"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuropharm.2019.107860","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T20:07:47Z","timestamp":1574453267000},"page":"107860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6104-8898","authenticated-orcid":false,"given":"Martin","family":"Jakobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrin J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107860_bib1","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/mp.2017.142","article-title":"Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation","volume":"23","author":"Akwa","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107860_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchemneu.2018.12.001","article-title":"Fornix deep brain stimulation induces reduction of hippocampal synaptophysin levels","volume":"96","author":"Aldehri","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2019.107860_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/jnnp.2008.154948","article-title":"Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months","volume":"80","author":"Alvarez","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107860_bib4","first-page":"334","article-title":"Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease","volume":"50","author":"Benabid","year":"1987","journal-title":"Appl. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jalz.2012.01.011","article-title":"Alzheimer's disease: pathogenesis and prevention","volume":"8","author":"Braak","year":"2012","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2019.107860_bib6","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107860_bib7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.neubiorev.2013.07.001","article-title":"A revised limbic system model for memory, emotion and behaviour","volume":"37","author":"Catani","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.107860_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/brain\/awm288","article-title":"Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease","volume":"131","author":"Ch\u00e9telat","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107860_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.121.3137.217","article-title":"Chemopallidectomy: an investigative technique in geriatric parkinsonians","volume":"121","author":"Cooper","year":"1955","journal-title":"Science (80-"},{"key":"10.1016\/j.neuropharm.2019.107860_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1126\/science.119.3091.417","article-title":"Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders","volume":"119","author":"Cooper","year":"1954","journal-title":"Science (80-"},{"key":"10.1016\/j.neuropharm.2019.107860_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3171\/jns.1958.15.3.0244","article-title":"Chemopallidectomy and chemothalamectomy","volume":"15","author":"Cooper","year":"1958","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2019.107860_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of Parkinsonism -- chronic treatment with L-dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1474-4422(13)70014-0","article-title":"Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial","volume":"12","author":"Dodel","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib15","doi-asserted-by":"crossref","first-page":"D63","DOI":"10.1002\/mds.10143","article-title":"Mechanisms of deep brain stimulation","volume":"17","author":"Dostrovsky","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0404.1966.tb01188.x","article-title":"Treatment of Parkinson's syndrome with L-dopa. A double blind study","volume":"42","author":"Fehling","year":"1966","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2019.107860_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133957","article-title":"High-frequency stimulation of the rat entopeduncular nucleus does not provide functional or morphological neuroprotection from 6-hydroxydopamine","volume":"10","author":"Fischer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107860_bib18","first-page":"6786","article-title":"Subthalamic nucleus deep brain stimulation employs trkB signaling for neuroprotection and","volume":"37","author":"Fischer","year":"2017","journal-title":"Funct. Restor."},{"key":"10.1016\/j.neuropharm.2019.107860_bib19","doi-asserted-by":"crossref","first-page":"16356","DOI":"10.1038\/s41598-017-16690-x","article-title":"Subthalamic nucleus deep brain stimulation does not modify the functional deficits or Axonopathy induced by nigrostriatal \u03b1-synuclein overexpression","volume":"7","author":"Fischer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.107860_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1528-1167.2010.02536.x","article-title":"Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy","volume":"51","author":"Fisher","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107860_bib21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease","volume":"362","author":"Follett","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1179\/016164103101201922","article-title":"Omental transpositionto the brain as a surgical method for treating Alzheimer's disease","volume":"25","author":"Goldsmith","year":"2003","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2019.107860_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.brs.2015.07.044","article-title":"Rapid modulation of protein expression in the rat hippocampus following deep brain stimulation of the fornix","volume":"8","author":"Gondard","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2019.107860_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2017.3762","article-title":"Bilateral deep brain stimulation of the nucleus basalis of meynert for Parkinson disease dementia a randomized clinical trial","volume":"75","author":"Gratwicke","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nurt.2008.02.001","article-title":"What happened to posteroventral pallidotomy for Parkinson's disease and dystonia?","volume":"5","author":"Gross","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2019.107860_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.21295","article-title":"Memory enhancement induced by hypothalamic\/fornix deep brain stimulation","volume":"63","author":"Hamani","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature15694","article-title":"Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice","volume":"526","author":"Hao","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107860_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.brs.2016.05.013","article-title":"Deep brain stimulation of the nucleus basalis of meynert in Alzheimer's dementia: potential predictors of cognitive change and results of a long-term follow-up in eight patients","volume":"9","author":"Hardenacke","year":"2016","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2019.107860_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/epi.12534","article-title":"Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation\u00a0: final results of the RNS System Pivotal trial","volume":"55","author":"Heck","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2019.107860_bib30","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1007\/s00429-015-1144-2","article-title":"Fornix deep brain stimulation enhances acetylcholine levels in the hippocampus","volume":"221","author":"Hescham","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2019.107860_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00429-016-1188-y","article-title":"Fornix deep brain stimulation induced long-term spatial memory independent of hippocampal neurogenesis","volume":"222","author":"Hescham","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2019.107860_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S2215-0366(17)30371-1","article-title":"Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial","volume":"4","author":"Holtzheimer","year":"2017","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2019.107860_bib33","first-page":"163","article-title":"Thalamotomy for Parkinson's disease","volume":"62","author":"Hurtig","year":"1985","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2019.107860_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","article-title":"The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core","volume":"6","author":"Jagust","year":"2010","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.neuropharm.2019.107860_bib35","doi-asserted-by":"crossref","first-page":"e9575","DOI":"10.15252\/emmm.201809575","article-title":"Cellular, molecular, and clinical mechanisms of action of deep brain stimulation\u2014a systematic review on established indications and outlook on future developments","volume":"11","author":"Jakobs","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease","volume":"9","author":"J\u00f6nhagen","year":"1998","journal-title":"Dement. Geriatr. Cognit. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib37","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107860_bib38","first-page":"119","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase 1 clinical trial","volume":"63","author":"Kim","year":"2015","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neuropharm.2019.107860_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","volume":"18","author":"Koprich","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107860_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.26890","article-title":"Current applications and limitations of surgical treatments for movement disorders","volume":"32","author":"Krack","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/mp.2014.32","article-title":"Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's dementia","volume":"20","author":"Kuhn","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107860_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.53.4.871","article-title":"Globus pallidus deep brain stimulation for generalized dystonia: clinical and PET investigation","volume":"53","author":"Kumar","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107860_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1042-3680(18)30479-0","article-title":"Pallidotomy for Parkinson's disease","volume":"6","author":"Laitinen","year":"1995","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2019.107860_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.22089","article-title":"A phase i trial of deep brain stimulation of memory circuits in Alzheimer's disease","volume":"68","author":"Laxton","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/2019.4.JNS181761","article-title":"Current and future directions of deep brain stimulation for neurological and psychiatric disorders","volume":"132","author":"Lee","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2019.107860_bib46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-180121","article-title":"Deep brain stimulation targeting the fornix for mild Alzheimer dementia (the ADvance trial): a two year follow-up including results of delayed activation","volume":"64","author":"Leoutsakos","year":"2018","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neuropharm.2019.107860_bib47","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(12)62188-6","article-title":"Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial","volume":"381","author":"Lipsman","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107860_bib48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jnnp-2015-310972","article-title":"Bilateral adaptive deep brain stimulation is effective in Parkinson's disease","volume":"87","author":"Little","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107860_bib49","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S1353-8020(13)70013-0","article-title":"The functional role of beta oscillations in Parkinson's disease","volume":"20","author":"Little","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-160017","article-title":"A phase II study of fornix deep brain stimulation in mild Alzheimer's disease","volume":"54","author":"Lozano","year":"2016","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neuropharm.2019.107860_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neuron.2013.01.020","article-title":"Probing and regulating dysfunctional circuits using deep brain stimulation","volume":"77","author":"Lozano","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107860_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.27228","article-title":"The changing landscape of surgery for Parkinson's Disease","volume":"33","author":"Lozano","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbrc.2015.07.007","article-title":"Comparison between \u03b1-synuclein wild-type and A53T mutation in a progressive Parkinson's disease model","volume":"464","author":"Lu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2019.107860_bib54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.brs.2017.11.012","article-title":"Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks","volume":"11","author":"Mann","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2019.107860_bib56","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199911253412207","article-title":"Treatment of Alzheimer's disease","volume":"341","author":"Mayeux","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jnc.13649","article-title":"Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation","volume":"139","author":"McIntyre","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107860_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/acn3.682","article-title":"Deep brain stimulation: potential for neuroprotection","volume":"6","author":"McKinnon","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib59","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4088\/JCP.v67n0801","article-title":"Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year","volume":"67","author":"Merrill","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107860_bib60","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/brain\/awv095","article-title":"Visual-spatial memory may be enhanced with theta burst deep brain stimulation of the fornix: a preliminary investigation with four cases","volume":"138","author":"Miller","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107860_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2047-9158-1-10","article-title":"Drug therapy in patients with Parkinson's disease","volume":"1","author":"Mueller","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2019.107860_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.24947","article-title":"Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T \u03b1-synuclein Parkinson's disease rat model","volume":"81","author":"Musacchio","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/WNL.0000000000002401","article-title":"GPi vs STN deep brain stimulation for Parkinson disease","volume":"86","author":"Odekerken","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107860_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mds.26882","article-title":"Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation","volume":"32","author":"Pal","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000244663","article-title":"Pallidotomy and thalamotomy in Parkinson's disease","volume":"3","author":"Phillips","year":"1961","journal-title":"Gerontol. Clin."},{"key":"10.1016\/j.neuropharm.2019.107860_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3171\/2015.6.JNS15716","article-title":"Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial","volume":"125","author":"Ponce","year":"2017","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2019.107860_bib67","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection","volume":"44","author":"Rodriguez","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.brs.2014.11.020","article-title":"Deep brain stimulation influences brain structure in Alzheimer's disease","volume":"8","author":"Sankar","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2019.107860_bib69","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease (Seminar)","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107860_bib70","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","article-title":"Neurostimulation for Parkinson's disease with early motor complications","volume":"368","author":"Schuepbach","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tins.2018.03.015","article-title":"Fornical closed-loop stimulation for Alzheimer's disease","volume":"41","author":"Senova","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107860_bib72","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.parkreldis.2010.02.008","article-title":"Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus","volume":"16","author":"Shaw","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2019.107860_bib73","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/01.wnl.0000316197.04157.6f","article-title":"Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study","volume":"71","author":"Silverberg","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107860_bib74","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneurol.2012.590","article-title":"Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease","volume":"69","author":"Smith","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib75","first-page":"652","article-title":"Results of thalamotomy for Parkinson's disease","volume":"89","author":"Speakman","year":"1963","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.neuropharm.2019.107860_bib76","first-page":"123","article-title":"Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex","volume":"1","author":"Spieles-Engemann","year":"2011","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.neuropharm.2019.107860_bib77","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1523\/JNEUROSCI.3100-11.2011","article-title":"Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory","volume":"31","author":"Stone","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107860_bib78","first-page":"68","article-title":"What happened to VIM thalamotomy for Parkinson's disease?","volume":"46","author":"Tasker","year":"1983","journal-title":"Appl. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2019.107860_bib79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2006.08.082","article-title":"Protection of nigral cell death by bilateral subthalamic nucleus stimulation","volume":"1120","author":"Temel","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107860_bib80","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.WNL.0000086371.78447.D2","article-title":"Deep brain stimulation of the VIM thalamic nucleus modifies several features of essential tremor","volume":"61","author":"Vaillancourt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107860_bib81","first-page":"797","article-title":"Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity","volume":"38","author":"Vander Borght","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2019.107860_bib82","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/brain\/awm137","article-title":"Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys","volume":"130","author":"Wallace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.107860_bib83","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/npp.2017.100","article-title":"Entorhinal cortical deep brain stimulation rescues memory deficits in both young and old mice genetically engineered to model Alzheimer's disease","volume":"42","author":"Xia","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107860_bib84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.conb.2017.08.004","article-title":"Striatal synapses, circuits, and Parkinson's disease","volume":"48","author":"Zhai","year":"2018","journal-title":"Curr. Opin. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:04:49Z","timestamp":1758438289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819304265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":84,"alternative-id":["S0028390819304265"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107860","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107860"}}